Virafin

Patanjali Anti-Allopathy Ad, a Window Into All That’s Wrong With Our Healthcare

COVID-19: India Has a Habit of Bad Clinical Trials

Dr Reddy’s Revealed More About 2-DG, and Its Approval Is More Confusing Now

In the Time of COVID-19, ‘What’s the Harm’ Prescriptions Are Not Harmless

In India, Drugs for COVID Are Being Tested, Approved in Ways That Should Worry Us

COVID in India: 35 Questions for K. VijayRaghavan, V.K. Paul and Balram Bhargava

DCGI Approves Virafin for Moderate COVID. Where’s the Evidence It Works?